New CPG: Hypermagnesaemia
Hypermagnesaemia is a new CPG that will be considered for PIC endorsement in December 2021
Hypermagnesaemia is a new CPG that will be considered for PIC endorsement in December 2021
The acutely swollen joint was an existing RCH CPG that will be considered for PIC endorsement in December 2021.
Food allergy – IgE mediated food allergy is a new CPG
Asthma preventer treatment in adolescents 12 years + is a brand-new CPG
Links to CPGs published in August and September 2021 plus details of topics considered by the CPG Committee
Family violence was an existing Victorian CPG that will be considered for PIC endorsement in October 2021
COVID-19 was an existing PIC CPG and the update includes new sections regarding immunisation and PIMS-TS. It will be considered for continued PIC endorsement in October 2021
Bone and joint infection was an existing RCH CPG that was previously called Osteomyelitis and septic arthritis. It will be considered for PIC endorsement in October 2021.
Serotonin toxicity is an existing Victorian CPG that will be considered for PIC endorsement in August.
Eucalyptus oil poisoning is an existing Victorian CPG that will be considered for PIC endorsement in August.